Oligoastrocytomas is a part of a group of brain tumor called “gliomas”. Glioma tumor is originated in the brain or spine. Oligoastrocytomas contains both astrocytoma cells and oligodendroglioma. About 2.3% of the brain tumors reported are diagnosed as oligoastrocytomas. Oligoastrocytomas is divided into two parts, low grade and anaplastic. According to the WHO grading system, anaplastic oligoastrocytomas are usually identify as grade 1 and grade 2 but sometimes they appear to be grade 4.  Anaplastic oligoastrocytomas can be characterized by high cellularity, conspicuous cytologic atypism, microvascular proliferation, mitotic activity and necrosis.  Patients suffering from this condition show symptoms like headache, seizure and speech or motor changes. According to the American Brain Cancer Association, clinical trials for the treatment of this tumor are in process to minimize the recurrence rate of anaplastic oligoastocytoma caused after the surgical removal of tumor or chemotherapy and radiation therapy session.

Scope of the Report:

This report studies the Anaplastic Oligoastrocytoma market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Anaplastic Oligoastrocytoma market by product type and applications/end industries.

Anaplastic oligoastrocytomas market is offers potential opportunities to cancer care industry.  Factors contributing the growth of anaplastic oligoastrocytomas market are rising geriatric population, increasing incidence of anaplastic oligoastrocytomas and increasing pace of clinical trials for novel drug development. Moreover factors such as advancement in technology and innovations in diangositc techniques is expected to drive the growth of anaplastic oligoastrocytoma market over the forecast period. However, lack of specific treatment and critical diagnosis of anaplastic oligoastrocytoma is the major challenge for anaplastic oligoastrocytomas market.

The global Anaplastic Oligoastrocytoma market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Anaplastic Oligoastrocytoma.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Tocagen

Shandong Lanjin Pharmaceuticals

Keryx Biopharmaceuticals

Insys Therapeutics

Rush University Medical Center

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Chemotherapy

Radiation

Market Segment by Applications, can be divided into

Hospitals

Cancer Centers

Surgical Centers

Table of Contents

1 Anaplastic Oligoastrocytoma Market Overview

1.1 Product Overview and Scope of Anaplastic Oligoastrocytoma

1.2 Classification of Anaplastic Oligoastrocytoma by Types

1.2.1 Global Anaplastic Oligoastrocytoma Revenue Comparison by Types (2017-2023)

1.2.2 Global Anaplastic Oligoastrocytoma Revenue Market Share by Types in 2017

1.2.3 Chemotherapy

1.2.4 Radiation

1.3 Global Anaplastic Oligoastrocytoma Market by Application

1.3.1 Global Anaplastic Oligoastrocytoma Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Cancer Centers

1.3.4 Surgical Centers

1.4 Global Anaplastic Oligoastrocytoma Market by Regions

1.4.1 Global Anaplastic Oligoastrocytoma Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Anaplastic Oligoastrocytoma Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Anaplastic Oligoastrocytoma Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Anaplastic Oligoastrocytoma Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Anaplastic Oligoastrocytoma Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Anaplastic Oligoastrocytoma Status and Prospect (2013-2023)

1.5 Global Market Size of Anaplastic Oligoastrocytoma (2013-2023)

2 Manufacturers Profiles

2.1 Tocagen

2.1.1 Business Overview

2.1.2 Anaplastic Oligoastrocytoma Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Tocagen Anaplastic Oligoastrocytoma Revenue, Gross Margin and Market Share (2016-2017)

2.2 Shandong Lanjin Pharmaceuticals

2.2.1 Business Overview

2.2.2 Anaplastic Oligoastrocytoma Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Shandong Lanjin Pharmaceuticals Anaplastic Oligoastrocytoma Revenue, Gross Margin and Market Share (2016-2017)

2.3 Keryx Biopharmaceuticals

2.3.1 Business Overview

2.3.2 Anaplastic Oligoastrocytoma Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Keryx Biopharmaceuticals Anaplastic Oligoastrocytoma Revenue, Gross Margin and Market Share (2016-2017)

2.4 Insys Therapeutics

2.4.1 Business Overview

2.4.2 Anaplastic Oligoastrocytoma Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Insys Therapeutics Anaplastic Oligoastrocytoma Revenue, Gross Margin and Market Share (2016-2017)

2.5 Rush University Medical Center

2.5.1 Business Overview

2.5.2 Anaplastic Oligoastrocytoma Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Rush University Medical Center Anaplastic Oligoastrocytoma Revenue, Gross Margin and Market Share (2016-2017)

3 Global Anaplastic Oligoastrocytoma Market Competition, by Players

3.1 Global Anaplastic Oligoastrocytoma Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Anaplastic Oligoastrocytoma Players Market Share

3.2.2 Top 10 Anaplastic Oligoastrocytoma Players Market Share

3.3 Market Competition Trend

4 Global Anaplastic Oligoastrocytoma Market Size by Regions

4.1 Global Anaplastic Oligoastrocytoma Revenue and Market Share by Regions

4.2 North America Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

4.3 Europe Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

4.5 South America Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

5 North America Anaplastic Oligoastrocytoma Revenue by Countries

5.1 North America Anaplastic Oligoastrocytoma Revenue by Countries (2013-2018)

5.2 USA Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

5.3 Canada Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

5.4 Mexico Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

6 Europe Anaplastic Oligoastrocytoma Revenue by Countries

6.1 Europe Anaplastic Oligoastrocytoma Revenue by Countries (2013-2018)

6.2 Germany Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

6.3 UK Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

6.4 France Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

6.5 Russia Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

6.6 Italy Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Anaplastic Oligoastrocytoma Revenue by Countries

7.1 Asia-Pacific Anaplastic Oligoastrocytoma Revenue by Countries (2013-2018)

7.2 China Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

7.3 Japan Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

7.4 Korea Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

7.5 India Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

8 South America Anaplastic Oligoastrocytoma Revenue by Countries

8.1 South America Anaplastic Oligoastrocytoma Revenue by Countries (2013-2018)

8.2 Brazil Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

8.3 Argentina Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

8.4 Colombia Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Anaplastic Oligoastrocytoma by Countries

9.1 Middle East and Africa Anaplastic Oligoastrocytoma Revenue by Countries (2013-2018)

9.2 Saudi Arabia Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

9.3 UAE Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

9.4 Egypt Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

9.5 Nigeria Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

9.6 South Africa Anaplastic Oligoastrocytoma Revenue and Growth Rate (2013-2018)

10 Global Anaplastic Oligoastrocytoma Market Segment by Type

10.1 Global Anaplastic Oligoastrocytoma Revenue and Market Share by Type (2013-2018)

10.2 Global Anaplastic Oligoastrocytoma Market Forecast by Type (2018-2023)

10.3 Chemotherapy Revenue Growth Rate (2013-2023)

10.4 Radiation Revenue Growth Rate (2013-2023)

11 Global Anaplastic Oligoastrocytoma Market Segment by Application

11.1 Global Anaplastic Oligoastrocytoma Revenue Market Share by Application (2013-2018)

11.2 Anaplastic Oligoastrocytoma Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Cancer Centers Revenue Growth (2013-2018)

11.5 Surgical Centers Revenue Growth (2013-2018)

12 Global Anaplastic Oligoastrocytoma Market Size Forecast (2018-2023)

12.1 Global Anaplastic Oligoastrocytoma Market Size Forecast (2018-2023)

12.2 Global Anaplastic Oligoastrocytoma Market Forecast by Regions (2018-2023)

12.3 North America Anaplastic Oligoastrocytoma Revenue Market Forecast (2018-2023)

12.4 Europe Anaplastic Oligoastrocytoma Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Anaplastic Oligoastrocytoma Revenue Market Forecast (2018-2023)

12.6 South America Anaplastic Oligoastrocytoma Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Anaplastic Oligoastrocytoma Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Anaplastic Oligoastrocytoma Picture

Table Product Specifications of Anaplastic Oligoastrocytoma

Table Global Anaplastic Oligoastrocytoma and Revenue (Million USD) Ma